The combination of ervogastat plus clesacostat was more effective at resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis in patients with biopsy-confirmed MASH ...
Prevalence and influence on outcome of Neuregulin- (NRG1), HER2/neu- and HER3- expression in patients with metastatic colorectal cancer (mCRC) treated with irinotecan-based first-line regimens (FUFIRI ...
Our studies use a variety of technological platforms including chemical and genetic screens to explore functionally active fatty acids and other individual lipids and nutrients which have both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results